Talphera (TLPH) Interest & Investment Income (2011 - 2026)
Talphera (TLPH) recorded quarterly Interest & Investment Income of $169000.0 in Q1 2026, up 108.64% quarter-over-quarter from $81000.0 in Q3 2025, and up 144.93% on a YoY basis from $69000.0 in Q1 2025.
Talphera (TLPH) Interest & Investment Income (2011 - 2026) Analysis & Trends
Talphera's Interest & Investment Income history runs 15 years deep, the most recent figure standing at $169000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 144.93% year-over-year to $169000.0; the TTM figure through Mar 2026 stood at $402000.0 (down 23.86% YoY), while the FY2024 annual figure was $679000.0, down 52.05% from the prior year.
- Interest & Investment Income was $169000.0 for Q1 2026 at Talphera, up from $81000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $858000.0 in Q2 2023 to a low of $38000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $178937.5 across 5 years, with a median of $147500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income surged 1582.35% in 2023, then plunged 76.57% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $137000.0 in 2022, then climbed by 24.82% to $171000.0 in 2023, then tumbled by 39.77% to $103000.0 in 2024, then dropped by 21.36% to $81000.0 in 2025, then soared by 108.64% to $169000.0 in 2026.
- The last three Interest & Investment Income figures came in at $169000.0 (Q1 2026), $81000.0 (Q3 2025), and $83000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Talphera | 56.51 Mn | 56.51 Mn | - | 169,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169,000.00 |
| Sep 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Jun 30, 2024 | 201,000.00 |
| Mar 31, 2024 | 220,000.00 |
| Dec 31, 2023 | 171,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Jun 30, 2023 | 858,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 140,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 32,000.00 |
| Jun 30, 2021 | -16,000.00 |
| Mar 31, 2021 | 76,000.00 |